Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.675 USD | +0.41% | -4.18% | +156.64% |
05-08 | Transcript : ChromaDex Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Earnings Flash (CDXC) CHROMADEX CORPORATION Reports Q1 Revenue $22.2M, vs. Street Est of $23.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+156.64% | 276M | |
+28.81% | 49.18B | |
+1.20% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.76% | 26.09B | |
-22.17% | 18.71B | |
+7.87% | 13.26B | |
+32.46% | 12.32B | |
-0.31% | 11.99B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex : B Riley Raises ChromaDex' Price Target to $18 from $7, Cites Favorable Clinical Studies Reflecting Potentially Broad Relevance; Keeps Buy Rating